UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 播種性転移した去勢感受性前立腺癌の治療法の概要overview of the treatment of disseminated castration sensitive prostate cancer [show details]
… agonist thus produces a combined androgen blockade. Combined androgen blockade with a first-generation antiandrogen is widely used for two to four weeks during the initiation of treatment with a GnRH agonist …
2. 去勢感受性前立腺癌の初期全身療法initial systemic therapy for castration sensitive prostate cancer [show details]
… antiandrogens to produce a combined androgen blockade during the initial period of treatment to prevent a disease flare; they also may be used in conjunction with antiandrogens for long-term therapy. Intermittent …
3. 中リスク、高リスク、超高リスクの限局性前立腺癌と臨床的に明らかなリンパ節転移陽性前立腺癌患者の初期管理initial management of regionally localized intermediate high and very high risk prostate cancer and those with clinical lymph node involvement [show details]
… after treatment . In the Scandinavian Prostate Cancer Group 7 trial, 875 men with locally advanced or high-risk prostate cancer were randomly assigned to three months of combined androgen blockade followed…
4. 限局性前立腺癌治療後の血清PSAの上昇：全身療法rising serum psa after treatment for localized prostate cancer systemic therapy [show details]
… received definitive treatment for localized disease. Monitoring PSA after definitive treatment of localized prostate cancer with either radiation therapy (RT) or radical prostatectomy… combined androgen blockade (CAB; a GnRH agonist or orchiectomy plus an antiandrogen),…
5. 悪性唾液腺腫瘍：再発性および転移性疾患の治療malignant salivary gland tumors treatment of recurrent and metastatic disease [show details]
… salivary duct carcinomas) with recurrent, metastatic, or locally advanced disease were treated with combined androgen blockade (leuprolide plus bicalutamide) . The mean androgen receptor positivity was 85 percent …

Japanese Journal

症例 Combined androgen blockade療法中にNeuroendocrine differentiationをきたした前立腺癌の1例

北本興市郎,林皓章,玉田聡 [他],江崎和芳,川嶋秀紀,杉村一誠,仲谷達也
泌尿器科紀要 51(1), 33-35, 2005-01
… 85歳男性.患者は3年半前に排尿困難で受診し,前立腺生検でpoorly differentiated adenocarcinoma,T3bN0M0と診断された.Combined androgen blockade(CAB)療法で軽快したが,今回,再び排尿困難で受診となり,直腸診で前立腺腫大を認めたため入院となった.検査では貧血と軽度の腎機能障害を認め,腫瘍マーカーのPSAは感度以下で,CEAとCA19-9は正常値,NSEとPro-GRPが著明に上昇していた.またMRI T2強調像で内部不均一な前立腺,精嚢の著 …
NAID 120002141379